Atlas Trials

Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa

Clinical trial NCT04582669 · TERMINATED

Trial details

NCT number
NCT04582669
Sponsor
Montefiore Medical Center
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Hidradenitis Suppurativa
Start date
2022-01-24
Primary completion
2022-10-12
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.